Stay updated on Setmelanotide in LEPR Deficiency Obesity Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in LEPR Deficiency Obesity Clinical Trial page.

Latest updates to the Setmelanotide in LEPR Deficiency Obesity Clinical Trial page
- Check6 days agoChange DetectedThe study record is displayed with details on the trial’s design, eligibility, locations, and outcomes, along with results history and study documents.SummaryDifference53%

- Check13 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0. The study record is still displaying a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA site-wide NIH banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check48 days agoChange DetectedRemoved the 403 Forbidden page that previously blocked access to the study details on ClinicalTrials.gov, restoring the ability to view the study record.SummaryDifference0.5%

- Check55 days agoChange DetectedA 403 Forbidden page is now shown for the study record, indicating access is blocked and replacing the prior study content view.SummaryDifference19%

Stay in the know with updates to Setmelanotide in LEPR Deficiency Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in LEPR Deficiency Obesity Clinical Trial page.